Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epoetin Alpha with Carboplatin and Paclitaxel in Recurrent Platinum-Sensitive Ovarian Cancer
NCT00189371Phase 3Terminated
- Sponsor
- AGO Study Group
- Start
- Feb 2004
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 3 trial of epoetin alfa in anemia, sponsored by AGO Study Group. Started Feb 2004; status: terminated.
02
Drugs
epoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00189371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00189371.